封面：  标题：Peptide Half-Life Extension I: Fatty-Acid Acylation and Albumin BindingWhy lipidation became a clinically validated strategy for longer-acting peptide medicinesWhat does lipidation actually change?Fatty-acid acylation is often described as a simple conjugation step: attach a lipid chain to a

封面图：Beyond Half-Life: Six Routes to Longer-Acting Peptide Therapeutics Extending the half-life of a peptide is not always the same as extending its therapeutic value. The more relevant development goal is to create an exposure profile that supports the intended pharmacology, dosing interval, and the

Sichuan Pukang Pharmaceutical Phase II Facility Commissioned, Expanding Manufacturing Capacity for Long-Acting Peptide Raw Materials On May 15, 2026, the Phase II facility of Sichuan Pukang Pharmaceutical was officially completed and commissioned. Figure 1: Completion Ceremony for Phase II of Sichua

Diabodies are noncovalent dimers of single-chain antibody fragments that retain the avidity of intact IgG but have more favorable blood clearance than intact IgG. Radiometals offer a wide range of half-lives and emissions for matching imaging and therapy requirements and provide facile labeling of c

Welcome to visit us at Shanghai&Milan CPHI in 2024！